Delivery Order SPE2DB24D3014-SPE2DB26FKRVD
- Not listed
- The Defense Logistics Agency awarded a $26,830.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes, with an ultimate completion date of August 6, 2025. This competitive award, issued on August 5, 2025, carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $13,626.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes, with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a $10,048.89 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Wezlana 90 mg/ml syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 20, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $55,296.33 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Wezlana 90 mg/ml syringes. This non-set-aside, firm fixed price contract is scheduled for completion by July 28, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,991.07 to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by September 29, 2025. The award was issued on September 26, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order falls under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $48,074.88 delivery order for Wezlana 90 mg/ml syringes on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $70,310.56 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Wezlana 90 mg/mL syringes. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The ultimate completion date is September 4, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a $71,048.38 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Wezlana 90 mg/mL syringes. The contract utilizes firm fixed pricing and carries an ultimate completion date of June 20, 2025. This competitively awarded delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract...
- The Defense Logistics Agency awarded a $18,191.77 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Wezlana 90 mg/mL syringes, with a completion date of June 20, 2025. This non-set-aside contract was competitively awarded and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $138,973.05 by the Defense Logistics Agency for the supply of Wezlana 90 mg/mL syringes. The contract, issued on September 29, 2025, with a completion date of September 30, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB26FKRVDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,286.29 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/mL syringes, with an ultimate completion date of October 27, 2025. This competitively awarded, non-set-aside delivery order employs firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio with DLA encompasses a wide range of pharmaceutical products, medical supplies, brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Wezlana syringes aligns with the contractor's demonstrated capability to fulfill federal medical supply requirements through the DLA Troop Support Medical prime vendor contract, which enables global pharmaceutical support for military healthcare programs and government healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 10/24/25 |